NEUROENDOCRINE CARCINOMA OF THE SKIN

Clinical trials for NEUROENDOCRINE CARCINOMA OF THE SKIN explained in plain language.

Never miss a new study

Get alerted when new NEUROENDOCRINE CARCINOMA OF THE SKIN trials appear

Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA OF THE SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug combo aims to shrink rare skin cancer before surgery

Disease control Ongoing

This study is testing whether giving two drugs, lenvatinib and pembrolizumab, before surgery can help people with Merkel cell carcinoma, a rare and aggressive skin cancer. The goal is to shrink the tumor as much as possible to make surgery more effective and potentially improve l…

Matched conditions: NEUROENDOCRINE CARCINOMA OF THE SKIN

Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

NEUROENDOCRINE CARCINOMA OF THE SKIN

Get alerted when new NEUROENDOCRINE CARCINOMA OF THE SKIN trials appear

New drug combo aims to shrink rare skin cancer before surgery